Back to hamad.qa
عربي
Staff login

Publications

2025

  1. Abdo Meyiah, Mohammad A. Al-Mterin, Khaled Murshed, Eyad Elkord. (2025). Association of Expression of Immune Checkpoints in Tumor-Infiltrating CD4+ T Lymphocytes with Disease-Free Survival in Colorectal Cancer Patients. Cancer Research and Therapy Connect, 1 (Article ID: 0006). https://doi.org/10.69709/CIConnect.2025.119991

  2. Abdulrahman Al-Mashdali, Samah M​ Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed; Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence. Blood 2025; 146 (Supplement 1): 1326. doi: https://doi.org/10.1182/blood-2025-1326

  3. Abusal, A. M., Ali, M., Murshed, K., & Aqeel, F. (2025). Focal Crescentic Pauci-Immune Glomerulonephritis in Systemic Lupus Erythematosus: A Case Report. Glomerular diseases, 5(1), 425–430. https://doi.org/10.1159/000548897

  4. Ahmad, S., Boekhout, T., Al-Hatmi, A. M. S., Al-Harrasi, A., Khateb, A. M., Al Dhaheri, F., Bin Shuraym, H., Thomsen, J., Alobaid, K., Asadzadeh, M., Taj-Aldeen, S. J., Alwasel, S., Alfouzan, W., Khan, Z., & Salah, H. (2025). Epidemiology of candidemia, candiduria and emerging Candidozyma (Candida) auris across Gulf Cooperative Council countries and Yemen in the Arabian Peninsula. Mycoses, 68(6), e70073. https://doi.org/10.1111/myc.70073

  5. Ahmed, B., Al-Khames Aga, Q., Cheung, K. L., de Boniface, J., Gnant, M., Cardoso, M. J., Rakha, E., Elumalai, T., Harbeck, N., Kaidar-Person, O., & Agrawal, A. (2025). Treatment strategies for triple-negative primary breast cancer in older women: a systematic review. JNCI Cancer Spectrum, 9(3), pkaf049. https://doi.org/10.1093/jncics/pkaf049

  6. Al-Abdulla, M. N., AlSrami, A., Takiddin, A. H., Murshed, K., & Steinhoff, M. (2025). Rare presentation of lues maligna and nodular syphilis in an immunocompetent patient. JAAD Case Reports, 67, 47–50. https://doi.org/10.1016/j.jdcr.2025.09.051
  7. Alani, A. M. M., Al Mukdad, O., Hassan, Y. M. E., Al-Bozom, I., Zabara, A., Alfared, M. H., Kolleri, J. J., & Darweesh, A. (2025). Abdominal Leiomyoma in an Adult Transgender with Adrenogenital Syndrome: A Rare Case Report. AL-Kindy College Medical Journal, 21(1), 80–85. https://doi.org/10.47723/6sac8t53

  8. Al-Anbagi, U., Al Maslamani, M., Aboukamar, M., Hamed, M., Elmagboul, E., Kayanattath, R., Nashwan, A. J., & Salehi, A. (2025). From Diarrhea to Bacteremia: Extended-Spectrum Beta-Lactamase (ESBL)-Producing Shigella in a Rare Clinical Scenario. Cureus, 17(2), e78566. https://doi.org/10.7759/cureus.78566

  9. Alfarsi, L. H., Ansari, R. E., Erkan, B., Fakroun, A., Craze, M. L., Aleskandarany, M. A., Cheng, K. W., Ellis, I. O., Rakha, E. A., & Green, A. R. (2025). SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Scientific Reports, 15(1), 2805. https://doi.org/10.1038/s41598-025-87292-1

  10. Algethami, M., Shoqafi, A., Lashen, A., Alqahtani, S., Spicer, J., ALtayyar, A., Tosun, Ç., Jeyapalan, J. N., Mongan, N. P., James, V., Rakha, E. A., & Madhusudan, S. (2025). Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities. Scientific Reports, 15(1), 28579. https://doi.org/10.1038/s41598-025-11052-4

  11. Alharbi, M. S., Moursi, S. A., Alshammari, A., Aboras, R., Rakha, E., Hossain, A., Alshubrumi, S., Alnazha, K., Khaja, A. S. S., & Saleem, M. (2025). Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies. Virulence, 16(1), 2580160. https://doi.org/10.1080/21505594.2025.2580160

  12. Ali, Maisa, et al. (2025). Significance, Clinical Spectrum, and Microbiological Evaluation of Actinomyces Blood Stream Infections. IJID Regions, 17, 100769. https://doi.org/10.1016/j.ijregi.2025.100769

  13. Ali, R., Algethami, M., Sheha, A., Alqahtani, S., Altayyar, A., Lashen, A., Rakha, E., Sulaiman, A. A., Madhusudan, S., & Ramotar, D. (2025). PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling. Oncotarget, 16, 362–378. https://doi.org/10.18632/oncotarget.28720

  14. Al-Mansoori, H., Sharaf Eldean, M. Z., Alhyari, A., & Tabouni, M. (2025). Beyond the Lungs: A Rare Case of Extrapulmonary Tuberculosis Presenting With Neck Vein Thrombosis and Seizure. Case Reports in Infectious Diseases, 2025, 4888774. https://doi.org/10.1155/crdi/4888774

  15. Al-Mashdali, Abdulrahman & Muthanna, Bassam & Soliman, Dina & Mohamed, Shehab. (2025). Efficacy and safety of CAR-t cell therapy in richter transformation: A systematic review. Blood, 146, 8089–8089. https://doi.org/10.1182/blood-2025-8089

  16. Almozyan, S., Babaei-Jadidi, R., Aljohani, A., Youssefi, S., Dalleywater, W., Kadam, P., Spencer-Dene, B., Rakha, E., Ilyas, M., & Shams Nateri, A. (2025). Wnt/GSK-3β mediates posttranslational modifications of FLYWCH1 to regulate intestinal epithelial function and tumorigenesis in the colon. Cancer Communications, 45(1), 9–14. https://doi.org/10.1002/cac2.12625

  17. Almuzghi, F., Elzouki, I., Moursi, M. O., Thakur, A. A., & Petkar, M. (2025). Sweet Syndrome With Painless Skin Lesions and Myopericarditis: A Case Report and Literature Review. Clinical Case Reports, 13, e70153. https://doi.org/10.1002/ccr3.70153

  18. Al-Romaihi, H. E., et al. (2025). Prevalence of hepatitis C virus infection in Qatar's resident population based on a national screening campaign. Scientific Reports, 15(1), 13481. https://doi.org/10.1038/s41598-025-96722-z

  19. Alshammari, A. D., Salem, A. M., Almarshedy, S. M., Rakha, E., & Saleem, M. (2025). Multidrug-resistant gram-negative bacteria in ICU patients of a tertiary care hospital in Saudi Arabia: distribution of carbapenemase genes in clinical and rectal swab samples. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(10), 14175–14188. https://doi.org/10.1007/s00210-025-04194-9

  20. Amna Gameil, Suhair El ajez, Omnya Abdalla, Wafa Mohammed, Dina Soliman, Samah Kohla, Aliaa Amer, Yahya Mulikandathil, Ibrahim Ganwo, Anas Hamad, Honar Charif, Feryal Hilmi; Unmasking PNH: Epidemiological and clinical insights from Qatar. Blood 2025; 146 (Supplement 1): 6722. doi: https://doi.org/10.1182/blood-2025-6722

  21. Atallah, N., Makhlouf, S., Li, X., Zhang, Y., Mongan, N. P., & Rakha, E. (2025). Prediction of Response to Anti-HER2 Therapy Using A Multigene Assay. Modern Pathology, 38(4), 100713. https://doi.org/10.1016/j.modpat.2025.100713

  22. Atallah, N., Makhlouf, S., Li, X., Zhang, Y., Mongan, N. P., & Rakha, E. (2025). Erratum to “Prediction of Response to Anti-HER2 Therapy Using A Multigene Assay” [Modern Pathology 38 (2025) 100713]. Modern Pathology, 38(9), 100861. https://doi.org/10.1016/j.modpat.2025.100861

  23. Atallah, N. M., Makhlouf, S., Nabil, M., Ibrahim, A., Toss, M. S., Mongan, N. P., & Rakha, E. (2025). Characterisation of HER2-Driven Morphometric Signature in Breast Cancer and Prediction of Risk of Recurrence. Cancer Medicine, 14(8), e70852. https://doi.org/10.1002/cam4.70852

  24. Atallah, N. M., Quinn, C., & Rakha, E. (2025). HER2 expression in breast cancer: evidence gaps and challenges. NPJ Precision Oncology, 10(1), 6. https://doi.org/10.1038/s41698-025-01209-9

  25. Ayoub, H. H., et al. (2025). Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance method. Public Health, 249, 106016. https://doi.org/10.1016/j.puhe.2025.106016

  26. Azza Abdalla, Abdulrahman Al-Mashdali, Feryal Hilmi, Naseema Gangat, Farhad Ravandi, Dina Soliman, & Shehab Fareed. (2025). Plasmacytoid dendritic cell-associated acute myeloid leukemia (pDC-AML): A comprehensive review. Blood, 146(Supplement 1), 6925. https://doi.org/10.1182/blood-2025-6925

  27. Baba, S. K., Alblooshi, S. S. E., Yaqoob, R., Behl, S., Al Saleem, M., Rakha, E. A., Malik, F., Singh, M., Macha, M. A., Akhtar, M. K., Houry, W. A., Bhat, A. A., Al Menhali, A., Zheng, Z. M., & Mirza, S. (2025). Human papilloma virus (HPV) mediated cancers: an insightful update. Journal of Translational Medicine, 23(1), 483. https://doi.org/10.1186/s12967-025-06470-x

  28. Ben Abid, F., Ittaman, A. V., Ibrahim, E. B., Al-Wali, W., Hamed, M. M. M., Abdellatif, A., Chaponda, M., Khatatneh, M. J., Hassan, A., Al-Romaihi, H. E. H. R., Tsui, C. K., Hadi, H. A., & Maslamani, M. A. (2025). Serogroup W invasive meningococcal disease outbreak in Qatar following travel to Umrah. Journal of Infection and Public Health, 18(11), 102945. https://doi.org/10.1016/j.jiph.2025.102945

  29. Chemaitelly, H., et al. (2025). Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: A national cohort study in Qatar. eLife, 14. https://doi.org/10.7554/eLife.103690

  30. Chemaitelly, H., et al. (2025). Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar. Vaccine, 62, 127556. https://doi.org/10.1016/j.vaccine.2025.127556

  31. Chemaitelly, H., et al. (2025). Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron. Nature, 639(8056), 1024–1031. https://doi.org/10.1038/s41586-024-08511-9

  32. Chemaitelly, H., et al. (2025). Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants. BMC Infectious Diseases, 25(1), 1028. https://doi.org/10.1186/s12879-025-11410-7

  33. Chemaitelly, H., et al. (2025). Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An economic analysis. PLoS ONE, 20(9), e0331654. https://doi.org/10.1371/journal.pone.0331654

  34. Chemaitelly, H., et al. (2025). Immune histories and natural infection protection during the omicron era. Communications Medicine, 5(1), 262. https://doi.org/10.1038/s43856-025-00974-9

  35. Dalton, L., & Rakha, E. (2025). Transcriptomic classifiers do not reliably predict lymph node involvement in breast Cancer: Insights from three large cohorts. European Journal of Surgical Oncology, 51(10), 110354. https://doi.org/10.1016/j.ejso.2025.110354

  36. Dina Soliman, Fadel Alqatati, Imran Nazir, Deena Mudawi, Abdulrahman Al-Mashdali, Feryal Hilmi, Shehab Fareed; Systemic mastocytosis with concurrent plasma cell myeloma: A rare a literature-based review of clinical, molecular, and pathologic features. Blood 2025; 146 (Supplement 1): 7522. doi: https://doi.org/10.1182/blood-2025-7522

  37. Eid, S. S., Ali, A., Shah, N., Alawadat, A. I., AbuHejleh, M., Al-Bozom, I., & Al-Sulaiti, G. (2025). Adult tentorial medulloblastoma mimicking meningioma: A case report and systematic review. Surgical Neurology International, 16, 143. https://doi.org/10.25259/SNI_10_2025

  38. Elajez, R. H., Bakdach, D., Al Balushi, S., Zaqout, A., Alattar, R., Abdallah, T., Awouda, W., Wilson, G., Al-Wali, W., Ibrahim, E., & Alsoub, H. (2025). Caspofungin versus anidulafungin in patients with invasive candidiasis: a retrospective study with propensity-score-matched analysis. Therapeutic Advances in Infectious Disease, 12, 20499361251344777. https://doi.org/10.1177/20499361251344777

  39. El Sheikh, S., Mansour, M. A., Provenzano, E., Shaaban, A., Lee, A., Mir, Y., McMillan-Slater, R., Carder, P., Di Palma, S., Boyd, C., Makhija, P., Warren, M., Pritchard, S., Deb, R., Ellis, I., Rakha, E., Quinn, C., & Pinder, S. (2025). Diagnostic interobserver variability of atypia assessment in columnar cell lesions among a group of expert breast pathologists in the United Kingdom and the Republic of Ireland, on behalf of the UK national coordinating committee for breast pathology. Histopathology, 86(6), 953–966. https://doi.org/10.1111/his.15402

  40. Evans, H., Kimani, P. K., Hiller, L., Tsang, Y. W., Sah, S., Gopalakrishnan, K., Boyd, C., Loughrey, M. B., Kelly, P. J., Boyle, D. P., Clark, D., Ellis, I. O., Ilyas, M., Rakha, E., Bickers, A., Roberts, I. S. D., Soares, M. F., Neil, D. A. H., Dunn, J. A., Azam, A., … Snead, D. (2025). What factors influence cellular pathologists' confidence in case reporting?. Virchows Archiv, 486(6), 1165–1173. https://doi.org/10.1007/s00428-024-03899-1

  41. Fadzai Chinyengetere, Leonardo P. A. Biral, Veronica Russell, Kikkeri N Naresh, Sarah Ondrejka, Jean Koff, Mette Pedersen, Catalina Amador, Elizabeth Thacker, Jennifer Chapman, Marja-Liisa Karjalainen-Lindsberg, Chee Leong Cheng, Cassandra Love, Payal Sojitra, Jennifer Shingleton, Einas Al-Kuwari, Sandeep Dave, & Dina Soliman. (2025). Genomic landscape of mycosis fungoides. Blood, 146(Supplement 1), 7062. https://doi.org/10.1182/blood-2025-7062

  42. Fareed, S., Al-Mashdali, A. F., Shwaylia, H., Mulikandathil, Y., Alshurafa, A., Aldali, S., Mudawi, D. S., Soliman, D., Abbas, F., Abdulgayoom, M., Yousef, A., Singh, K., Cherif, H., & Yassin, M. (2025). Clinical Characteristics and Treatment Outcomes of Acute Myeloid Leukemia in Adolescent and Young Adult versus Adult Patients: A Single-Center Experience in Qatar. Clinical Hematology International, 7(2), 55–64. https://doi.org/10.46989/001c.140933

  43. Ghali, M. S., Al Hassan, M. S., Goyal, R., & Abdelaal, A. (2025). An uncommon case of coexistence of thyrolipoma and angioinvasive follicular thyroid carcinoma with a background of lymphocytic thyroiditis: Clinical case report. International Journal of Surgery Case Reports, 133, 111526. https://doi.org/10.1016/j.ijscr.2025.111526

  44. Ghannam, S. F., Rutland, C. S., Allegrucci, C., Mather, M. L., Alsaleem, M., Bateman-Price, T. D., Patke, R., Ball, G., Mongan, N. P., & Rakha, E. (2025). Geometric characteristics of stromal collagen fibres in breast cancer using differential interference contrast microscopy. Journal of Microscopy, 297(2), 135–152. https://doi.org/10.1111/jmi.13361

  45. Hamdi, W. S., et al. (2025). Clinical characteristics and outcomes of viral respiratory infections in allogeneic haematopoietic stem cell transplantation recipients: A single-centre experience. Journal of Medical Microbiology, 74(9). https://doi.org/10.1099/jmm.0.002071

  46. Hamza, Y. P., Kacem, M. A. B. H., Al Molawi, N. H., Yassine, H. M., AlKhatib, H. A. M., Benslimane, F., Al-Remaihi, H. I. K. B., Awni El Kahlout, R., Ahmed El Kahlout, B. I., Al Khalili, H., Al Khalili, M. A., Doiphode, S. H., Elmagboul, E. B. I., Akhter, J., Al Kuwari, E. A. E., & Coyle, P. V. (2025). Patients in hospital with confirmed bacterial airway infection are significantly more likely to have a respiratory virus co-infection. Journal of Medical Microbiology, 74(7), 001996. https://doi.org/10.1099/jmm.0.001996

  47. Haque, M., Atallah, N., Patke, R., Harris, A. E., Woodcock, C. L., Varun, D., Thompson, R. L., Jackson-Oxley, J., Okui, C. H., Dean, A., Alsaleem, M., Rakha, E., Irshad, S., Davis, M. B., Jeyapalan, J. N., Mongan, N. P., & Rutland, C. S. (2025). Cardiotoxicity of breast cancer drug treatments. Translational Oncology, 55, 102352. https://doi.org/10.1016/j.tranon.2025.102352

  48. Harris, A. E., Lothion-Roy, J., Thompson, R. L., Haque, M., Woodcock, C. L., Alsaleem, M. A., Dean, A., Kariri, Y., Toss, M. S., Gudas, L. J., Green, A. R., Allegrucci, C., Davis, M. B., Irshad, S., Park, K. H., Madhusudan, S., Fray, R. G., Jeyapalan, J. N., Rutland, C. S., Rakha, E. A., … Mongan, N. P. (2025). Functional and clinical significance of the RNA m6A methyltransferase complex in breast cancer. NPJ Breast Cancer, 11(1), 147. https://doi.org/10.1038/s41523-025-00861-5

  49. Hedaya, L., Naja, K., Almuraikhy, S., Anwardeen, N., Elashi, A. A., Al-Asmakh, M., Zughaier, S. M., Espino-Guarch, M., Aldirbashi, O. Y., Davey, G. P., & Elrayess, M. A. (2025). N-Lactoyl Phenylalanine Disrupts Insulin Signaling, Induces Inflammation, and Impairs Mitochondrial Respiration in Cell Models. Cells, 14(16), 1296. https://doi.org/10.3390/cells14161296

  50. Hawraa Shawaylia, Noor Moustafa, Mohamad Dulli, Anil Yousaf, Ghasoub Rola, Dina Soliman, Deena Mudawi, Abdulrahman Al-Mashdali, Mohammed Termanini, fatma shwaylia, Hesham Elsabah, Anas Hamad, Honar Charif, Shehab Fareed; Thrombotic events as initial presentation of acute promyelocytic leukemia (APL): A literature-based review of patient-level data. Blood 2025; 146 (Supplement 1): 6894. doi: https://doi.org/10.1182/blood-2025-6894

  51. Huneity, A., Alahmad, Y. M., Bozom, I. A., Alhyari, A., Alaoud, A., & Kumar, R. (2025). An unusual mediastinal giant parathyroid adenoma: A rare case report. Radiology Case Reports, 20(4), 2213–2217. https://doi.org/10.1016/j.radcr.2025.01.068

  52. Jamaleddin, T., El-Akouri, K., Abiib, S., Mitri, R., Ramaswamy, M., Musa, S., Ali, R., Shahbeck, N., Al Rifai, H., Abdoh, G., Ben-Omran, T., Al-Dirbashi, O. Y., & Al-Shafai, M. (2025). Qatar's National Expanded Metabolic Newborn Screening Program: Incidence and Outcomes. International Journal of Neonatal Screening, 11(3), 50. https://doi.org/10.3390/ijns11030050

  53. Jean Koff, Veronica Russell, Rachel Kositsky, David Jaye, Michael Churnetski, Katelin Baird, Colin O'Leary, Christopher Flowers, Sirpa Leppä, Shaoying Li, Jessie Xu, Mette Pedersen, Anne Ortved Gang, Kikkeri N Naresh, Rex Au-Yeung, Jennifer Chapman, Amy Chadburn, Izidore S. Lossos, Sarah Ondrejka, Abner Louissaint, Eric Tse, Cassandra Love, Devang Thakkar, Clayton Parker, Choon Kiat Ong, Andrew Evans, Emily F. Mason, Yan Jiong, Magdalena Czader, Andrew Evens, Dina Soliman, Yuri Fedoriw, Sandeep Dave, & Jonathon Cohen. (2025). Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status. Blood, 146(Supplement 1), 352. https://doi.org/10.1182/blood-2025-352

  54. Kanbour, A., Alnajjar, A., AbuHaweeleh, M. N., Al-Bozom, I., Wazwaz, B., Haroon, A., Madhar, R., & Saman, H. (2025). Metastatic lung pleomorphic giant cell carcinoma treated with multimodality systemic anti-cancer treatment, a two-year journey: A case report. Respiratory Medicine Case Reports, 58, 102330. https://doi.org/10.1016/j.rmcr.2025.102330

  55. Kariri, Y. A., Alsaleem, M., Al-Kawaz, A., Alhatlani, B. Y., Mongan, N. P., Green, A. R., & Rakha, E. A. (2025). Cell division cycle 6 is an independent prognostic biomarker in breast cancer. Pathology, 57(3), 297–304. https://doi.org/10.1016/j.pathol.2024.09.006

  56. Katayama, A., Makhlouf, S., Toss, M. S., Oyama, T., & Rakha, E. A. (2025). Nuclear morphological characterisation of lobular carcinoma variants: a morphometric study. Histopathology, 86(5), 813–823. https://doi.org/10.1111/his.15390

  57. Khaldi, Hiba, et al. (2025). Clinical features and treatment outcomes in women with neuroendocrine cervical cancer: A systematic review. International Journal of Gynecological Cancer, 35(11), 102441. https://doi.org/10.1016/j.ijgc.2025.102441

  58. Khan, A. A., Jasim, N. K. E., Al-Mannai, N. E. A. H., Ata, F., Goyal, R., & Jaber, T. (2025). Clinical outcomes of patients with Bethesda III or IV cytology on fine needle aspiration of thyroid nodules: A retrospective study. Endocrinology, Diabetes & Metabolism, 8(5), e70076. https://doi.org/10.1002/edm2.70076

  59. Lashen, A. G., Toss, M. S., Rutland, C. S., Green, A. R., Mongan, N. P., & Rakha, E. (2025). Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer. Pathobiology, 92(1), 18–27. https://doi.org/10.1159/000540790

  60. Lee, A. H. S., Hodi, Z., Abbas, A., Ellis, I. O., & Rakha, E. A. (2025). HER2-positive grade 1 invasive carcinomas of the breast. Histopathology, 86(2), 278–284. https://doi.org/10.1111/his.15315
  61. Lee, A. H. S., Rakha, E. A., Hodi, Z., Abbas, A., Ellis, I. O., & Chan, S. (2025). Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy. Histopathology, 87(1), 58–67. https://doi.org/10.1111/his.15426
  62. Madan, E., Palma, A. M., Vudatha, V., Kumar, A., Bhoopathi, P., Wilhelm, J., Bernas, T., Martin, P. C., Bilolikar, G., Gogna, A., Peixoto, M. L., Dreier, I., Araujo, T. F., Garre, E., Gustafsson, A., Dorayappan, K. D. P., Mamidi, N., Sun, Z., Yekelchyk, M., Accardi, D., … Gogna, R. (2025). Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells. Nature Biotechnology, 43(11), 1833–1847. https://doi.org/10.1038/s41587-024-02453-3

  63. Makhlouf, S., Almalki, N., Sheha, A., Atallah, N. M., Ibrahim, A., Toss, M., Mongan, N. P., & Rakha, E. A. (2025). Outcome prediction of oestrogen receptor-positive breast cancer based on a panel of oestrogen receptor-regulated genes. Histopathology, 87(6), 842–855. https://doi.org/10.1111/his.15557

  64. Mesilhy, R., Khan, M. N., Syed, A., Hourani, R., Cherif, H., Elsalkawi, Y., Khalid, H., Al-Mashdali, A., Soliman, D., Mudwai, D., Doi, S. A., & Mohamed, S. F. (2025). Comparative survival outcomes between therapy-related and de novo acute lymphoblastic leukemia in adults: a systematic review and meta-analysis. BMC Cancer, 26(1), 71. https://doi.org/10.1186/s12885-025-15366-4

  65. Meyiah, A., Khan, F. I., Alfaki, D. A., Murshed, K., Raza, A., & Elkord, E. (2025). The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy. Translational Oncology. https://doi.org/10.1016/j.tranon.2025.102307

  66. Mokaddas, E., Al-Jardani, A. K., Saeed, N. K., Doiphode, S., Senok, A., Joury, J., & Egaila, M. (2025). Invasive pneumococcal disease in the Gulf region: A narrative review of incidence, burden, and vaccine strategies. Frontiers in Public Health, 13, 1589366. https://doi.org/10.3389/fpubh.2025.1589366

  67. Mohamad Dulli, Abdulrahman Al-Mashdali, Afra Ahmed, Ashraf Ahmed, Mohammad Afana, Mohammad Altermanini, Nabeel Qasem, Noor Moustafa, Samah Kohla, Hawraa Shawaylia, Dina Soliman, Mohammed Yasin, Shehab Mohamed; Prevalence and risk of aortic aneurysms in JAK2-positive myeloproliferative neoplasms: A multi-study review. Blood 2025; 146 (Supplement 1): 7349. doi: https://doi.org/10.1182/blood-2025-7349

  68. Moursi, S. A., Saleem, M., Alharbi, M. S., Rakha, E., Alshammari, A., Aboras, R., Hossain, A., Alshubrumi, S., Alnazha, K., Alkhateeb, A., & Syed Khaja, A. S. (2025). Resistance patterns and virulence factors of Pseudomonas aeruginosa in hospitalized patients: A Saudi Arabian study. Scientific Reports, 15(1), 38118. https://doi.org/10.1038/s41598-025-18388-x

  69. Mudawi, D., Al-Mashdali, A. F., Tawalbeh, A., Szabados, L., Soliman, D. S., & Fareed, S. (2025). Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab. Case Reports in Oncology, 18(1), 620–629. https://doi.org/10.1159/000545930

  70. Pareja, F., Bhargava, R., Borges, V. F., Brogi, E., Canas Marques, R., Cardoso, F., Desmedt, C., Harigopal, M., Lakhani, S. R., Lee, A., Leone, J. P., Linden, H., Lord, C. J., Marchio, C., Merajver, S. D., Rakha, E., Reis-Filho, J. S., Richardson, A., Sawyer, E., Schedin, P., … Oesterreich, S. (2025). Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes. NPJ breast cancer, 11(1), 6. https://doi.org/10.1038/s41523-025-00719-w

  71. Rakha, E., Kariri, Y. A., Alsaleem, M., Kariri, T. A., Alkharaiji, M., Asad, M., & Rakha, E. A. (2025). Keratin 24 Predicts Poor Prognosis in Breast Cancer. Pathobiology : journal of immunopathology, molecular and cellular biology, 92(5), 251–264. https://doi.org/10.1159/000546022

  72. Rakha, E. A., & Quinn, C. (2025). Controversies regarding encapsulated papillary carcinoma of the breast: an approach to evaluation and categorisation. Histopathology, 86(4), 497–513. https://doi.org/10.1111/his.15310

  73. Rakha, E. A., Quinn, C., Fox, S., Masannat, Y. A., Karakatsanis, A., & Dixon, J. M. (2025). Reply to the Editor: Reassessing margin standards in breast-conserving therapy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 51(2), 109504. https://doi.org/10.1016/j.ejso.2024.109504

  74. Rakha, E. A., Quinn, C., Raymond, W., Allison, K. H., Badve, S. S., Brogi, E., Callagy, G., Charafe-Jauffret, E., Chen, C. J., Chen, Y. Y., Collins, L. C., Cserni, G., Djerroudi, L., Jaffer, S., Foschini, M. P., Gobbi, H., Gudi, M., Harada, O., Kulka, J., Kuroda, H., … Tan, P. H. (2025). Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 38(5), 100734. https://doi.org/10.1016/j.modpat.2025.100734

  75. Rakha, E. A., & Wen, H. Y. (2025). Neuroendocrine Neoplasms of the Breast: Evolving Concepts and Reappraisal of Classification. Surgical pathology clinics, 18(4), 651–663. https://doi.org/10.1016/j.path.2025.07.001

  76. Sabooni, S., Salah, H., Singh, R., Al-Qadi, K., Taj-Aldeen, S. J., & Ibrahim, E. (2025). Comparison of four diagnostic techniques for Cryptosporidium detection in Qatar. Qatar Medical Journal, 2025(3), 78. https://doi.org/10.5339/qmj.2025.78

  77. Saidy, B., Gull, L., Hacker, A. G., Rakha, E. A., Green, A. R., Ellis, I. O., Martin, S. G., & Storr, S. J. (2025). Expression of the zinc-finger transcription factor Osterix (SP7) in invasive breast cancer and its prognostic significance. Cellular oncology (Dordrecht, Netherlands), 48(4), 1035–1045. https://doi.org/10.1007/s13402-025-01062-9

  78. Saleem, M., Ahmad, I., Salem, A. M., Almarshedy, S. M., Moursi, S. A., Syed Khaja, A. S., Rakha, E., Azhar, A., Ashammari, M. N., Almalaq, H., Alshurtan, K., & Khan, M. S. (2025). Molecular and genetic analysis of methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary care hospital in Saudi Arabia. Naunyn-Schmiedeberg's archives of pharmacology, 398(6), 7559–7569. https://doi.org/10.1007/s00210-024-03771-8

  79. Saleem, M., Moursi, S. A., Altamimi, T. N. A., Alharbi, M. S., Alaskar, A. M., Hammam, S. A. H., Rakha, E., Syed Muhammad, O. I., Almalaq, H. A., Alshammari, M. N., & Syed Khaja, A. S. (2025). Prevalence and Molecular Characterization of Carbapenemase-Producing Multidrug-Resistant Bacteria in Diabetic Foot Ulcer Infections. Diagnostics (Basel, Switzerland), 15(2), 141. https://doi.org/10.3390/diagnostics15020141

  80. Sasi, S., Abdelmajid, A., Salah, H., Ibrahim, E., Al-Maslamani, M., & Al-Khal, A. (2025). Recurrent vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans: A retrospective study. Cureus, 17(2), e78906. https://doi.org/10.7759/cureus.78906

  81. Sasi, S., Ali, G. A., Salah, H., Goravey, W., & Maslamani, M. A. (2025). Central line-associated Cyberlindnera fabianii fungemia: A case report and review of diagnostic and therapeutic challenges. Qatar Medical Journal, 2025(3), 90. https://doi.org/10.5339/qmj.2025.90

  82. Sasi, S., Goravey, W., Balushi, S. A., Ibrahim, E., Iqbal, J., Khal, A. A., Maslamani, M. A., & Ali, G. A. (2025). Epidemiological, clinical, and microbiological characteristics of listeriosis in Qatar: A retrospective study. Qatar medical journal, 2025(3), 87. https://doi.org/10.5339/qmj.2025.87

  83. Sasi, S., Hamed, M. M. M., Abdel Hadi, H. E. A., Goravey, W., Ibrahim, E., Abid, F. B., Doiphode, S., Wilson, G., Kashaf, A. S. A., Al-Maslamani, M., & Al-Khal, A. (2025). Emerging Insights into Corynebacterium Kroppenstedtii Complex Associated Breast Abscesses: A Retrospective Study. Infection and drug resistance, 18, 2439–2449. https://doi.org/10.2147/IDR.S501554

  84. Shahid, Z., Mahfouz, A., Ahmed, A., Rahhal, A., Soliman, D., Imran, M., Abdalla, E., Bedardeen, U., Elmurtada, M., Ibrahim, F., Yassin, M., & Mohamed, S. (2025). Eptifibatide Induced Thrombocytopenia in Acute Coronary Syndrome: A Real-World Data. Journal of Heart Valve Disease Innovation, 30(1), 01-06. https://doi.org/10.36923/jhvd.v30i1.245

  85. Shamoon R, Elhassan O, Al-Emadi L, Zabara A, Petkar MA, Sayed S, Mohammad OH. (2025). Neuroendocrine carcinoma causing common bile duct obstruction: a case report. Oxford Medical Case Reports, 2025(4), omaf011. https://doi.org/10.1093/omcr/omaf011

  86. Shehab Fareed, Alanoud Alshmarri, Dina Soliman, Duha Naji, Aliaa Amer, Samah Kohla, ibrahim Ganow, Abdulrahman Al-Mashdali, Mohammed Yasin, Feryal Hilmi; Plasmacytoid dendritic cell in a setting of acute myeloid leukaemia: A single-center case series from tertiary cancer hospital. Blood 2025; 146 (Supplement 1): 6914. doi: https://doi.org/10.1182/blood-2025-6914

  87. Shehab Mohamed, Abdulrahman Al-Mashdali, Anas Babiker, Noor Moustafa, Wafa Mohammed, Mohamad Dulli, Dina Soliman, Deena Mudawi, Sara Aldali, Rowan Mesilhy, Honar Charif; PARP inhibitors and the rising incidence of secondary myelodysplastic syndrome and acute myeloid leukemia: A comprehensive meta-analysis. Blood 2025; 146 (Supplement 1): 7390. doi: https://doi.org/10.1182/blood-2025-7390

  88. Shoqafi, A., Ali, R., Lashen, A., Jeyapalan, J. N., Ibrahim, A., Toss, M. S., Rakha, E. A., Algethami, M., Alqahtani, S., Mongan, N. P., Ramotar, D., & Madhusudan, S. (2025). Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers. International journal of molecular sciences, 26(7), 3239. https://doi.org/10.3390/ijms26073239

  89. Shoqafi, A., Ibrahim, A., Lashen, A., Toss, M. S., Alqahtani, S., Miligy, I., Algethami, M., Sheha, A., Jeyapalan, J. N., Mongan, N. P., Green, A. R., Rakha, E. A., & Madhusudan, S. (2025). Clinicopathological Significance of Transcription Factor p73 in Breast Cancers: Protein Expression and Transcriptomic Study. Biomedicines, 13(10), 2484. https://doi.org/10.3390/biomedicines13102484

  90. Snead, D. R., Azam, A. S., Thirlwall, J., Kimani, P., Hiller, L., Bickers, A., Boyd, C., Boyle, D., Clark, D., Ellis, I., Gopalakrishnan, K., Ilyas, M., Kelly, P., Loughrey, M., Neil, D., Rakha, E., Roberts, I. S., Sah, S., Soares, M., Tsang, Y., … Dunn, J. (2025). Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study. Health technology assessment (Winchester, England), 29(30), 1–75. https://doi.org/10.3310/SPLK4325

  91. Soliman, D. S., Fareed, S., Chandra, P., Akiki, S., El-Omri, H., Ibrahim, F., Yassin, M., El Kourashy, S. A., Al-Sabbagh, A., & Al-Kuwari, E. (2025). Post-cytotoxic myeloid neoplasms: a comprehensive analysis of clinicopathologic, genetic profile, latency determinants, and potential prognostic predictors- a single centre study. Annals of hematology, 104(10), 5095–5110. https://doi.org/10.1007/s00277-025-06651-0

  92. Soliman, D., Ibrahim, F., Rizvi, H., Petkar, M., Lengyel, Z., Sange, A. H., Alshurafa, A., & Yasin, R. (2025). Extensive Bone Marrow Involvement by BRAFV660E-Mutated Bi-Phenotypic Erdheim-Chester Neoplasm/Rosai-Dorfman Disease (Mixed Histiocytic Neoplasm) with Atypical Histological Features and Fulminant Hemophagocytosis. Case reports in oncology, 18(1), 602–612. https://doi.org/10.1159/000545775

  93. Sukik, L., et al. (2025). Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: A nationwide matched cohort study in Qatar. Scientific Reports, 15(1), 35179. https://doi.org/10.1038/s41598-025-19168-3

  94. Sukik, L., et al. (2025). Evaluating hospital admission data as indicators of COVID-19 severity: A national assessment in Qatar. Open Forum Infectious Diseases, 12(3), ofaf098. https://doi.org/10.1093/ofid/ofaf098

  95. Tan, P. H., Ellis, I. O., Allison, K. H., Badve, S. S., Brogi, E., Callagy, G., Charafe-Jauffret, E., Chen, C. J., Chen, Y. Y., Collins, L. C., Cserni, G., Djerroudi, L., Foschini, M. P., Fox, S. B., Gobbi, H., Gudi, M., Harada, O., Jaffer, S., Kulka, J., Kuroda, H., … Rakha, E. A. (2025). Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria. Histopathology, 87(2), 169–182. https://doi.org/10.1111/his.15455

  96. Thompson, R. L., Lothion-Roy, J., Bellows, E., Woodcock, C. L., Jackson-Oxley, J., Haque, M., Varun, D., Kumari, A. A., Alsaleem, M., de Brot, S., Ntekim, A., Muyangwa-Semanova, M., Rakha, E., Madhusudan, S., Archer, N., Fray, R. G., Irshad, S., Emes, R. D., Jeyapalan, J. N., Rutland, C. S., … Harris, A. E. (2025). The functional and therapeutic potential of epitranscriptomics in breast cancer. Epigenomics, 17(14), 1009–1028. https://doi.org/10.1080/17501911.2025.2542113
    ​
  97. Varun, D., Haque, M., Jackson-Oxley, J., Thompson, R., Kumari, A. A., Woodcock, C. L., Harris, A. E., Madhusudan, S., Rakha, E., Rutland, C. S., Mongan, N. P., & Jeyapalan, J. N. (2025). Epigenetic Therapies in Endocrine-Related Cancers: Past Insights and Clinical Progress. Cancers, 17(15), 2418. https://doi.org/10.3390/cancers17152418​​

Hamad Medical Corporation

HMC is the principal public healthcare provider in the State of Qatar, delivering the safest, most effective and most compassionate care to each and every one of our patients.

Latest Facebook Posts

Latest Twitter Posts

Privacy Notice. © Copyright - Hamad Medical Corporation by Corporate Communications Dept.
Top